tradingkey.logo

Cigna Group

CI

302.760USD

-3.200-1.05%
Close 09/12, 16:00ETQuotes delayed by 15 min
80.72BMarket Cap
16.09P/E TTM

Cigna Group

302.760

-3.200-1.05%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated2025-09-12

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
14 / 72
Overall Ranking
123 / 4724
Industry
Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 26 analysts
Buy
Current Rating
361.486
Target Price
+19.40%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 247.12B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 36.90% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.63%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.63%.
Fairly Valued
The company’s latest PE is 16.45, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 245.93M shares, decreasing 3.95% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 25.60M shares of this stock.

Financial Health

Currency: USD Updated2025-09-12

The company's current financial score is 7.99, which is higher than the Healthcare Providers & Services industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 65.50B, representing a year-over-year increase of 14.40%, while its net profit experienced a year-over-year increase of 577.62%.

Score

Industry at a Glance

Previous score
7.99
Change
0

Financials

7.49

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

7.62

Operational Efficiency

7.66

Growth Potential

8.36

Shareholder Returns

8.81

Company Valuation

Currency: USD Updated2025-09-12

The company’s current valuation score is 1.80, which is lower than the Healthcare Providers & Services industry's average of 2.15. Its current P/E ratio is 16.30, which is 9.21% below the recent high of 17.80 and -1.46% above the recent low of 16.54.

Score

Industry at a Glance

Previous score
1.80
Change
0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 14/72
No Data

Earnings Forecast

Currency: USD Updated2025-09-12

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Providers & Services industry's average of 7.66. The average price target for Cigna Group is 365.00, with a high of 415.00 and a low of 300.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 26 analysts
Buy
Current Rating
361.486
Target Price
+19.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

9
Total
21
Median
19
Average
Company name
Ratings
Analysts
Cigna Group
CI
26
UnitedHealth Group Inc
UNH
28
Humana Inc
HUM
27
Elevance Health Inc
ELV
24
Centene Corp
CNC
21
Molina Healthcare Inc
MOH
19
1
2

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated2025-09-12

The company’s current price momentum score is 9.36, which is higher than the Healthcare Providers & Services industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 319.95 and the support level at 268.42, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
8.98
Change
-1.92

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(2)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
0.619
Buy
RSI(14)
55.219
Neutral
STOCH(KDJ)(9,3,3)
62.793
Neutral
ATR(14)
5.076
Low Volatility
CCI(14)
110.448
Buy
Williams %R
41.220
Buy
TRIX(12,20)
0.198
Sell
StochRSI(14)
15.580
Sell
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
302.794
Sell
MA10
302.538
Buy
MA20
301.628
Buy
MA50
295.895
Buy
MA100
308.629
Sell
MA200
306.800
Sell

Institutional Confidence

Currency: USD Updated2025-09-12

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 7.19. The latest institutional shareholding proportion is 92.13%, representing a quarter-over-quarter decrease of 2.16%. The largest institutional shareholder is The Vanguard, holding a total of 25.60M shares, representing 9.59% of shares outstanding, with 1.05% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
26.02M
+0.17%
BlackRock Institutional Trust Company, N.A.
13.26M
-0.90%
State Street Global Advisors (US)
12.47M
-1.96%
MFS Investment Management
11.31M
+0.73%
T. Rowe Price Associates, Inc.
Star Investors
11.65M
+10.30%
8.89M
+1.34%
Fidelity Management & Research Company LLC
10.52M
+5.45%
Sanders Capital, LLC
7.99M
-0.81%
Geode Capital Management, L.L.C.
6.04M
+1.33%
GQG Partners, LLC
4.89M
+21.51%
1
2

Risk Assessment

Currency: USD Updated2025-09-12

The company's beta value is 0.49. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
5.50
Change
0
Beta vs S&P 500 index
0.47
VaR
+2.53%
240-Day Maximum Drawdown
+26.87%
240-Day Volatility
+32.19%
Return
Best Daily Return
60 days
+4.43%
120 days
+4.43%
5 years
+16.68%
Worst Daily Return
60 days
-10.23%
120 days
-10.23%
5 years
-10.92%
Sharpe Ratio
60 days
-0.35
120 days
-0.29
5 years
+0.48
Risk Assessment
Maximum Drawdown
240 days
+26.87%
3 years
+28.52%
5 years
+28.52%
Return-to-Drawdown Ratio
240 days
-0.46
3 years
-0.05
5 years
+0.32
Skewness
240 days
-0.74
3 years
+0.63
5 years
+0.12
Volatility
Realised Volatility
240 days
+32.19%
5 years
+28.00%
Standardised True Range
240 days
+2.62%
5 years
+2.13%
Downside Risk-Adjusted Return
120 days
-30.86%
240 days
-30.86%
Maximum Daily Upside Volatility
60 days
+17.23%
Maximum Daily Downside Volatility
60 days
+27.39%
Liquidity
Average Turnover Rate
60 days
+0.70%
120 days
+0.68%
5 years
--
Turnover Deviation
20 days
+6.28%
60 days
+12.99%
120 days
+8.82%

Peer Comparison

Currency: USD Updated2025-09-12
Cigna Group
Cigna Group
CI
6.83 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
Encompass Health Corp
EHC
7.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
Tenet Healthcare Corp
THC
7.45 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
Brightspring Health Services Inc
BTSG
7.29 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Progyny Inc
Progyny Inc
PGNY
7.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Privia Health Group Inc
Privia Health Group Inc
PRVA
7.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.

KeyAI